Pazopanib and Oral Cyclophosphamide in Women With Platinum-Resistant or -Refractory Epithelial Ovarian Cancer

PURPOSE: Women with recurrent, multiply-treated epithelial ovarian cancer (EOC) have unfavorable prognosis with limited treatment options after failure of platinum-based regimens. We report here a retrospective analysis of women with recurrent, platinum-resistant EOC treated with an oral regimen of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulia, Seema, Ghosh, Jaya, Bajpai, Jyoti, Rath, Sushmita, Maheshwari, Amita, Shylasree, T.S., Deodhar, Kedar, Thakur, Meenakshi, Gupta, Sudeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113132/
https://www.ncbi.nlm.nih.gov/pubmed/32228315
http://dx.doi.org/10.1200/JGO.19.00331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113132/
https://www.ncbi.nlm.nih.gov/pubmed/32228315
http://dx.doi.org/10.1200/JGO.19.00331

Ejemplares similares